Table 8.
Urine volume of after oral administration of TFX (n = 10)
| Groups | Dosage (mg/kg) |
Volume of urine (mL) | Total volume (mL) |
pH | |||||||
| 0–1 h | 1–3 h | 3–5 h | 5–7 h | 7–9 h | 9–11 h | 11–15 h | 15–24 h | ||||
| Control | - | 3.85 | 6.58 | 6.45 | 5.96 | 5.87 | 5.32 | 9.64 | 15.87 | 59.5 | 7.16 |
| Low dose | 2.3 | 4.01 | 6.83 | 6.51 | 5.84 | 5.96 | 5.66 | 10.35 | 17.12 | 62.3 | 6.84 |
| Medium dose | 4.6 | 5.67* | 8.12** | 8.07* | 7.46* | 7.28 | 6.39 | 11.24 | 18.09 | 72.3** | 6.76 |
| High dose | 9.2 | 5.56* | 8.27** | 8.11** | 7.38* | 7.36* | 6.74 | 10.97 | 18.53 | 72.9** | 6.65 |
| Furosemide | 2.0 | 11.2** | 12.7** | 9.18* | 7.84* | 6.35 | 4.32 | 7.63 | 10.97 | 70.2* | 6.88 |
p<0.05
p<0.01